News

Anemia linked to risk of death after stroke


 

red blood cells
Red blood cells

Anemia may increase the risk of death in older adults who have had a stroke, according to research published in the Journal of the American Heart Association.

An initial analysis of more than 8000 patients showed that anemia was associated with a higher risk of death for up to 1 year following ischemic or hemorrhagic stroke.

A second analysis of nearly 30,000 patients suggested the risk of dying from ischemic stroke is about 2 times higher in patients with anemia than those without it, and the risk of death from hemorrhagic stroke is about 1.5 times higher in anemic patients.

“So there’s the potential for a much poorer outcome if somebody comes in with stroke and they’re also anemic,” said study author Phyo Myint, MD, of the University of Aberdeen in Scotland.

Dr Myint and his colleagues first examined data from the UK Regional Stroke Register. This included 8013 patients with an average age of 78 who were admitted to the hospital with acute stroke between 2003 and 2015.

The team assessed the impact of anemia and hemoglobin levels at admission on death at different time points—inpatient, 7 days, 14 days, 1 month, 3 months, 6 months, and 1 year after stroke.

Anemia was associated with higher odds of death at most of the time points examined. And elevated hemoglobin was associated with a higher risk of death, mainly within the first month.

In addition to analyzing data from the UK Regional Stroke Registry, the researchers systematically reviewed relevant literature published to date. They compiled data from 20 previous studies, increasing the study population to 29,943 stroke patients.

In analyzing these patients, the researchers found that anemia on admission was associated with an increased risk of mortality in both ischemic stroke and hemorrhagic stroke. The odds ratios were 1.97 and 1.46, respectively.

The researchers believe this study emphasizes the impact of anemia on stroke outcomes and the need for increased awareness and interventions for stroke patients with anemia.

“One example of an intervention might be treating the underlying causes of anemia, such as iron deficiency, which is common in this age group,” said study author Raphae Barlas, a medical student at the University of Aberdeen.

“As the study has convincingly demonstrated, anemia does worsen the outcome of stroke, so it is very important that we identify at-risk patients and optimize the management.”

Recommended Reading

Genome-editing approach could treat SCD
MDedge Hematology and Oncology
How hydroxyurea fights sickle cell disease
MDedge Hematology and Oncology
Drivers of cardiac complications in sickle cell anemia
MDedge Hematology and Oncology
Products granted orphan designation for use in HSCT
MDedge Hematology and Oncology
Teva launches generic imatinib tablets in US
MDedge Hematology and Oncology
Method provides more accurate diagnosis of MDS, team says
MDedge Hematology and Oncology
Sickle cell trait doesn’t increase risk of death, study suggests
MDedge Hematology and Oncology
Light-based therapy may treat thrombocytopenia
MDedge Hematology and Oncology
Blood disorders prove costly for European economy
MDedge Hematology and Oncology
Radiologists no longer have higher risk of cancer-related death
MDedge Hematology and Oncology